iifl-logo

ICICI Pru Nifty Pharma Index Fund Dir G

ICICI Pru Nifty Pharma Index Fund Dir G

Fund Name

ICICI Prudential Mutual Fund

Scheme Name

ICICI Pru Nifty Pharma Index Fund Dir G

AMC

ICICI Prudential Mutual Fund

Type

:  Open

Category

Equity - Index

Launch Date

25-Nov-2022

Fund Manager

Nishit Patel

Net Assets (Rs. cr)

135.94

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

ICICI Pru Nifty Pharma Index Fund Dir G - Nav Details

Nav Date

:  22-Jul-2026

NAV [Rs.]

:  19.9377

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

ICICI Pru Nifty Pharma Index Fund Dir G- NAV Chart

ICICI Pru Nifty Pharma Index Fund Dir G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.92
4.11
14.81
17.69
15.65
21.67
-
21.09
Category Avg
0.8
1.09
2.05
3.8
1.09
13.27
11.62
7.86
Category Best
2.81
14.19
16.41
26.59
38.55
29.66
18.27
30.04
Category Worst
-2.01
-4.23
-11.67
-23.6
-24.09
0.01
7.92
-22.88

ICICI Pru Nifty Pharma Index Fund Dir G- Latest Dividends

No Records Found

ICICI Pru Nifty Pharma Index Fund Dir G- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology21.3115557628.97
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.031867412.28
EquityDr Reddy's LabsPharmaceuticals & Biotechnology8.948956312.15
EquityCiplaPharmaceuticals & Biotechnology8.918267312.11
EquityLaurus LabsPharmaceuticals & Biotechnology6.38571658.67
EquityLupinPharmaceuticals & Biotechnology6.34356818.63
EquityTorrent Pharma.Pharmaceuticals & Biotechnology5.23154187.12
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.72406696.42
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.58221224.87
EquityAlkem LabPharmaceuticals & Biotechnology3.5285984.78
EquityBioconPharmaceuticals & Biotechnology3.221048254.38
EquityMankind PharmaPharmaceuticals & Biotechnology3.11166354.23
EquityZydus Lifesci.Pharmaceuticals & Biotechnology3.00367604.08
EquityIpca Labs.Pharmaceuticals & Biotechnology2.55204093.47
EquityGland PharmaPharmaceuticals & Biotechnology2.14117082.92
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.03120282.76
EquityWockhardtPharmaceuticals & Biotechnology1.73121342.35
EquityAjanta PharmaPharmaceuticals & Biotechnology1.5561882.11
EquityAbbott IndiaPharmaceuticals & Biotechnology1.437661.94
EquityPiramal PharmaPharmaceuticals & Biotechnology1.12913851.53

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
ICICI Prudential Mutual Fund
Incorporation Date:
22-Jun-1993
Total Assets Managed (Cr.):
11,76,217.65
Trustee/s:
Mr. Lakshman Kumar Mylava, ICICI Prudential Trust Lt
Chairman:
NA
CEO / MD:
Mr. Nimesh Shah
CIO:
NA
President:
NA
Director/s:
Mr. Vijay Thacker, Mr. Nimesh Shah, Ms. Vibha Paul Rishi, Ms.Anubhuti Sanghai
Compliance Officer/s:
NA
Investor Service Officer/s:
Rajen Kotak
Fund Manager/s:
Nishit Patel
Auditors:
S.R.Batliboi & Co. LLP

OTHER INFORMATION

Registered Office:
One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051
Contact Nos:
022 26525000
Fax:
022 26528100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.